Limitations
eczema
FOOD ALLERGIES, ECZEMA
This trial has some limitations. First, the overall prevalence of EA was 8.4%, lower than the initially expected 15%. The reason for the low prevalence of EA was speculated to be strict skin care and aggressive topical corticosteroid therapy starting at age 1 month. Aggressive topical corticosteroid therapy in infants with eczema may decrease the incidence of food allergies.